GIQAR 2021 – The effect of Covid-19 pandemic on Quality Nov 11, 2021 October 2021 – CROss Alliance QA Unit attended the XXIX GIQAR meeting, sponsoring the […] Read more
CROss Alliance® successful outcome of Swissmedic GCP System Inspection Jul 27, 2021 July 2021 – As required by Federal Laws, CROSS activities are periodically subjected to […] Read more
Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition May 17, 2021 May 2021 – The relationship between Accelera and CROss Alliance® started a decade ago […] Read more
CROSS Research participation in phase 1 study with monoclonal antibody against SARS-COV2 Mar 9, 2021 March 2021 – CROss Alliance® is excited to share the news that on March […] Read more
Participation of CROss Alliance® in the Zurich Life Science Day 2021 Feb 11, 2021 February 2021 – On the 4th of February, Ursula Herranz, Business Development Unit Head […] Read more
Covid-19 – Phase I unit re-open Jun 23, 2020 June 2020 – We are relieved to announce that CROSS Research Phase I Unit […] Read more
Covid-19 – CROss Alliance® measures Apr 2, 2020 2nd April 2020 – Almost one month has passed since the violent outbreak of […] Read more
Covid-19 – CROss Alliance® update Mar 9, 2020 March 2020 – CROss Alliance® would like to inform its Sponsors and Collaborators that […] Read more
Merger by incorporation of CROSS Metrics SA in CROSS Research SA Jan 10, 2020 January 2020 – CROss Alliance® would like to announce that the two operative companies […] Read more
Merry Christmas & Happy New Year Wishes Dec 19, 2019 At CROss Alliance® Christmas time represents an opportunity to evaluate together the passing year […] Read more